• Application Information: Zika virus Capsid protein antibody

Catalog Number	GTX133317 ★★★★★ ( 1 )  ( 5 )
Product Name	Zika virus Capsid protein antibody See all Zika virus Capsid products
Applications	ICC/IF, WB
Application Note	Suggested dilution Reference Immunocytochemistry/ Immunofluorescence (ICC/IF) 1:100-1:1000*   Western Blot (WB) 1:500-1:20000* Y Not tested in other applications.  *Optimal dilutions/concentrations should be determined by the researcher.
Predicted Target Size	12 kDa (note)
Positive Controls	Zika virus Capsid-transfected 293T , Zika-infected Vero whole cell extracts , Zika Virus-PRVABC59 infected C6/36 cells , Zika virus Capsid-transfected 293T
Form Supplied	Liquid
Concentration	1.1 mg/ml (Please refer to the vial label for the specific concentration)
Purification	Purified by antigen-affinity chromatography.

As a multinational antibody manufacturer, GeneTex’s primary goal is to provide bioscience researchers with thoroughly validated reagents to accelerate their discovery.

Established in 1997 in San Antonio, Texas by scientists with expertise in clinical oncology, cancer biology, and infectious disease, the company’s initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists probing the underlying mechanisms common to many forms of cancer. GeneTex’s catalog has since expanded to offer a broad and diverse selection of antibody products covering a full range of research areas.

GeneTex is proud to offer the highest quality antibody reagents supported by extensive research, development, and validation. We are committed to the highest standards of product performance.